Systems biology of vaccination for seasonal influenza in humans.
Nat Immunol, 2011/7/10;12(8):786-95.
Nakaya HI[1], Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, Means AR, Kasturi SP, Khan N, Li GM, McCausland M, Kanchan V, Kokko KE, Li S, Elbein R, Mehta AK, Aderem A, Subbarao K, Ahmed R, Pulendran B
Affiliations
PMID: 21743478DOI: 10.1038/ni.2067
Impact factor: 31.25
Abstract
Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). TIV induced higher antibody titers and more plasmablasts than LAIV did. In subjects vaccinated with TIV, early molecular signatures correlated with and could be used to accurately predict later antibody titers in two independent trials. Notably, expression of the kinase CaMKIV at day 3 was inversely correlated with later antibody titers. Vaccination of CaMKIV-deficient mice with TIV induced enhanced antigen-specific antibody titers, which demonstrated an unappreciated role for CaMKIV in the regulation of antibody responses. Thus, systems approaches can be used to predict immunogenicity and provide new mechanistic insights about vaccines.
MeSH terms
Adaptive Immunity; Adolescent; Adult; Animals; Antibodies, Viral; Gene Expression Profiling; Hemagglutination Inhibition Tests; Humans; Immunity, Innate; Influenza Vaccines; Influenza, Human; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Orthomyxoviridae; Seasons; Systems Biology; Vaccination; Vaccines, Attenuated; Vaccines, Inactivated; Young Adult
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download